3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint

3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China

3/19/2025Visirna's VSA001 Achieves Positive Phase III Results in Treating FCS

3/19/2025CSPC Initiates Phase 3 Trial of SYS6010 for EGFR-Mutant NSCLC Patients

3/19/2025Hengrui Initiates Phase 2/3 Trial Combining SHR-A2102 and Adebrelimab ...

3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...

3/17/2025Visirna Announce Positive Topline Results from Phase 3 Trial of Ploza...

3/17/2025SinoCellTech Advances PD-1/VEGF Bispecific SCTB14 into Phase 2/3 for E...

3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China

3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...

3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China

3/14/2025Pyrotech's PTT-936 Gains Approval for Clinical Trials in China for Adv...

3/14/2025Roche's Itovebi (Inavolisib) Wins Approval in China for Advanced Breas...

3/13/2025AskBio Receives FDA Regenerative Medicine Advanced Therapy Designation...

3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...

3/12/2025Pfizer's PD-L1 Targeting ADC Receives Clinical Trial Approval in China

3/12/2025CSPC Advances Phase II Trial of Nectin-4 ADC SYS6002 for Advanced HNSC...

3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...

3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...

3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...

3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...

3/11/2025RockRoc Secures Pre-A+ Financing to Advance Macrophage-Based Cancer Th...

3/11/2025InnoCare Presents Promising Phase II Data on ICP-488 for Psoriasis

3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...

3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment

3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...

3/7/2025CStone Submits Clinical Trial Application in Australia for CS5001 in D...

3/5/2025CStone Announces First Patient Dosed in Global Trial of Trispecific An...

3/4/2025Hansoh Pharma's HS-20089 Advances to Phase III Trial for Platinum-Resi...

3/4/2025Longbio Pharma's LP-003 Shows Promising Results in Phase II CSU Trial

Page:10/18 Total number of articles:511: [First][<<] [8] [9] [10] [11] [12] [>>] [End]